Gene Symbol | Pearson Correlation Coefficient |
---|---|
SCNN1D | 0.916 |
CORO6 | 0.899 |
CUL9 | 0.898 |
NEIL1 | 0.887 |
IFT172 | 0.886 |
HOOK2 | 0.883 |
RTEL1 | 0.882 |
PTCH2 | 0.882 |
PKD1 | 0.88 |
TSC2 | 0.88 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
HAS2 | -0.448 |
OR4F5 | -0.445 |
C9orf135 | -0.443 |
AGTR1 | -0.436 |
IGF2BP2 | -0.436 |
ZNF114 | -0.424 |
PABPC4L | -0.421 |
OR4F29 | -0.415 |
CD8B | -0.414 |
KIAA0040 | -0.41 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB12872 | Vonicog Alfa | BiotechDrug | 109319-16-6 | Approved|Investigational | Enzyme |
DB13133 | Von Willebrand Factor Human | BiotechDrug | 109319-16-6 | Approved|Investigational | Enzyme |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ADAMTS13 mRNA" | 25614096 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of ADAMTS13 mRNA | 22100608 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the expression of ADAMTS13 mRNA | 25690898 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased mutagenesis of ADAMTS13 gene | 25435355 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of ADAMTS13 protein | 16689760 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of ADAMTS13 protein | 16689760 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of ADAMTS13 mRNA | 27392435 |
D002945 | Cisplatin | [Cisplatin co-treated with Paclitaxel] results in decreased expression of ADAMTS13 mRNA | 20705681 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased activity of ADAMTS13 protein | 17383642 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of ADAMTS13 mRNA | 27392435 |
C544151 | jinfukang | jinfukang results in increased expression of ADAMTS13 mRNA | 27392435 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 affects the expression of ADAMTS13 mRNA" | 24972896 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of ADAMTS13 mRNA | 21878173 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of ADAMTS13 protein | 21878173 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of ADAMTS13 mRNA | 16966085 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of ADAMTS13 mRNA | 26011545 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of ADAMTS13 mRNA" | 25620056 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of ADAMTS13 mRNA" | 25620056 |
D017239 | Paclitaxel | [Cisplatin co-treated with Paclitaxel] results in decreased expression of ADAMTS13 mRNA | 20705681 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of ADAMTS13 mRNA | 25895662 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of ADAMTS13 mRNA" | 26179874 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004222 | metalloendopeptidase activity | - | IEA | - |
GO:0005178 | integrin binding | - | TAS | 11557746 |
GO:0005509 | calcium ion binding | - | TAS | 11557746 |
GO:0005515 | protein binding | - | IPI | 12775718 16221672 18492805 25512528 |
GO:0008237 | metallopeptidase activity | - | TAS | 11557746 |
GO:0008270 | zinc ion binding | - | TAS | 11557746 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0006508 | proteolysis | - | IDA | 11535495 |
GO:0007160 | cell-matrix adhesion | - | NAS | 11557746 |
GO:0007229 | integrin-mediated signaling pathway | - | NAS | 11557746 |
GO:0009100 | glycoprotein metabolic process | - | NAS | 11557746 |
GO:0009636 | response to toxic substance | - | IEA | - |
GO:0014075 | response to amine | - | IEA | - |
GO:0016485 | protein processing | - | TAS | 11557746 |
GO:0030168 | platelet activation | - | NAS | 11557746 |
GO:0035864 | response to potassium ion | - | IEA | - |
GO:0043171 | peptide catabolic process | - | IDA | 11535495 |
GO:0071222 | cellular response to lipopolysaccharide | - | IEA | - |
GO:0071346 | cellular response to interferon-gamma | - | IEA | - |
GO:0071353 | cellular response to interleukin-4 | - | IEA | - |
GO:0071356 | cellular response to tumor necrosis factor | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005615 | extracellular space | - | IEA | - |
GO:0005788 | endoplasmic reticulum lumen | - | TAS | - |
GO:0009986 | cell surface | - | NAS | 11557746 |
GO:0031012 | extracellular matrix | - | TAS | 11557746 |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1643685 | Disease | TAS |
R-HSA-3781865 | Diseases of glycosylation | TAS |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | TAS |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-5083635 | Defective B3GALTL causes Peters-plus syndrome (PpS) | TAS |
R-HSA-5173105 | O-linked glycosylation | TAS |
R-HSA-5173214 | O-glycosylation of TSR domain-containing proteins | TAS |
R-HSA-597592 | Post-translational protein modification | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
17606444 | Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. (2007 Jul) | Swisher KK | Haematologica |
27067884 | Hemostatic Markers and Long-Term Risk of Intracerebral Hemorrhage in Postmenopausal Women. (2016 Jul) | Lee JM | J Stroke Cerebrovasc Dis |
29296746 | Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels. (2017 Jun 27) | Ma Q | Blood Adv |
27259465 | The unexpected beneficial role of smoking in preeclampsia. (2016 Aug 1) | Alpoim PN | Clin Chim Acta |
29669506 | Mutations and Common Polymorphisms in ADAMTS13 and vWF Genes Responsible for Increasing Risk of Thrombosis. (2018 Apr 18) | Haybar H | Cardiovasc Hematol Disord Drug Targets |